Letter to the Editor January 16, 2006

Galantamine-Induced QTc Prolongation

Matthew W. Nelson, PharmD, BCPP; Robert W. Buchanan, MD

J Clin Psychiatry 2006;67(1):166-167

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Galantamine is an acetylcholinesterase inhibitor that is approved for the treatment of mild to moderate Alzheimer’s dementia. It may also have beneficial effects in the treatment of schizophrenia.1,2 The following is a case report of a patient with schizophrenia who developed corrected QT interval (QTc) prolongation while receiving galantamine.’ ‹